HGT-3010

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameHGT-3010

Drug Alias Namealpha-N-acetylglucosaminidase-insulin-like growth factor II (Shire)Naglu-IGF-II (Shire)enzyme replacement therapy (Shire)HGT-3010

ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionAlpha-N-acetylglucosaminidase stimulants

TargetsAlpha-N-acetylglucosaminidase

Therapy Area/IndicationsMucopolysaccharidosis III

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesShire

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesShire

Active IndicationsN/A

Inactive IndicationsMucopolysaccharidosis III

Other Information

ATC CodeN/A